IFU subscription

Skip to content

For investors
Support
Webshop
Document portal

Diagnostic areas
Products
Services
Resources
About us

Contact us

Post-transplantation
Oncology
Hematology
Reproductive health
Cystic fibrosis
Cardiovascular diseases

Post-transplantation
One Lambda Devyser Accept cfDNA
One Lambda Devyser Chimerism NGS

Thalassemia
Devyser Thalassemia NGS

Hereditary cancer
Devyser BRCA NGS
Devyser HBOC NGS
Devyser BRCA PALB2 NGS
Devyser LynchFAP

Fetal RHD screening NIPT
Devyser RHD

Cystic fibrosis
Devyser CFTR Core
Devyser CFTR 68
Devyser CFTR NGS
Devyser CFTR Italia

Cardiovascular diseases
Devyser Thrombophilia
Devyser FH NGS
Devyser HFE
Devyser CVD

Male infertility
Devyser AZF Extension
Devyser AZF v2

Rapid aneuploidy analysis
Devyser Compact
Devyser Complete
Devyser Extend
Devyser Resolution 13
Devyser Resolution 18
Devyser Resolution 21
Devyser Resolution XY

Software
Advyser Solid organs
Advyser Chimerism
Amplicon Suite

Accessories
560 sizer orange
DEV-5 Dye set
Devyser Index plate A
Devyser Index plate LB-A
Devyser library clean

Devyser Genomic Laboratories

Events & webinars
IVDR
Knowledge hub
Whitepapers
Devyser blog
Frequently asked questions (FAQs)
Calculator for chimerism
Sequence coverage calculator
IFUs and certificates

Our company
Investors
Distributors
News and press
Career
Contact us

Diagnostic areas

Post-transplantation
Oncology
Hematology
Reproductive health
Cystic fibrosis
Cardiovascular diseases

Products

Post-transplantation
- One Lambda Devyser Accept cfDNA
- One Lambda Devyser Chimerism NGS
Thalassemia
- Devyser Thalassemia NGS
Hereditary cancer
Fetal RHD screening NIPT
- Devyser RHD
Cystic fibrosis
Cardiovascular diseases
Male infertility
- Devyser AZF Extension
- Devyser AZF v2
Rapid aneuploidy analysis
Software
Accessories

Services

Devyser Genomic Laboratories

Resources

Events & webinars
IVDR
Knowledge hub
Whitepapers
Devyser blog
Frequently asked questions (FAQs)
Calculator for chimerism
Sequence coverage calculator
IFUs and certificates

About us

Our company
Investors
Distributors
News and press
Career
Contact us

For investors
Support
Webshop
Document portal

Insights

WebBanner_Devyser_RHD-IVDR-approval_2024-11

News | December 2, 2024

Devyser achieves Class D IVDR approval for its RHD product

Devyser has received IVDR approval for its non-invasive fetal RHD screening product. This marks the first approval of a Class D product.

News | October 29, 2024

Devyser seeks to secure FDA approval for NGS test for kidney transplant monitoring

News | October 28, 2024

Devyser Compact achieves Class III approval in China

News | July 19, 2024

Devyser wins tender in Italy for its cystic fibrosis NGS test worth up to 5.9 million SEK

Diagnostic areas

Post-transplantation
Oncology
Hematology
Reproductive health
Cystic fibrosis
Cardiovascular diseases

Products and services

Kits and reagents
Our services

Resources

Events & webinars
Knowledge hub
Whitepapers
Devyser blog
Calculator for Chimerism
Sequence coverage calculator
IFUs and certificates

About us

Our company
Contact us
Distributors
News and press
Career
Whistleblowing policy

Investors

Press releases
Reports

© Devyser 2024

Privacy policy | Legal terms | About cookies